Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KS.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KS.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KS.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KS.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KS.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KS.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.19ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.19EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.19EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
HN.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-3870.61Germany
HN.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-2266.25Germany
HN.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
HN.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
HN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
HN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JN.1.47EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.47ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.47ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.47EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.47EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.57.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.57.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.57.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.57.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.57.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.57.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.57.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.57.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.44.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.44.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.44.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.44.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.44.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.44.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.44.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.44.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.2.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.2.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used